ALFAMA is a young pharmaceutical company dedicated to the development of small-molecule drugs for the combat against inflammation-related diseases.

ALFAMA's proprietary technologies hold the promise of contributing decisively to the prevention and cure of inflammatory diseases such as rheumatoid arthritis, asthma, psoriasis and IBD, as well as inflammation-related problems such as stroke, myocardial infarction, atherosclerosis and Alzheimer’s disease.

The core of ALFAMA's science is developed in Portugal, where the company was started, at state-of-the-art research facilities around the Lisbon area. The company’s financial and legal organization, on the other hand, complies with American standards and is based in Cambridge, Massachusetts (USA), where the holding company – ALFAMA Inc – is located.

ALFAMA's innovative science and its multi-national business approach have allowed the company to recruit top talent from around the world, even at its current early stage.
We welcome you to visit our web site and find out more about ALFAMA.

Click here for our contact information.